LLS News Network

News and information from The Leukemia & Lymphoma Society

News Releases

Man & Woman of the Year Sets New Fundraising Record

Rye Brook, NY (July 6, 2016) – What happens when community leaders across the country devote 10 weeks of their time and energy to raise funds to find cures for cancer? Records are broken. The Leukemia & Lymphoma Society’s (LLS) unique Man & Woman of the Year national campaign winners raised a record-breaking combined total of more than $800,000 for LLS’s goal to find cures for blood cancers and ens...

Peter Brock Elected Chair of LLS Board of Directors

Rye Brook, N.Y. (June 28, 2016) – Real estate developer Peter Brock will become chair of The Leukemia & Lymphoma Society’s (LLS) national board of directors effective July 1, 2016. His term will run through June 30, 2018. He has served as the board’s secretary/treasurer since July 1, 2015. Brock has decades of experience in developing commercial real estate throughout the U.S. He is currently a partner i...

Dr. Renzo Canetta Elected to LLS National Board of Directors

Rye Brook, N.Y. (June 28, 2016) – Renzo Canetta, M.D., former vice president of Oncology Global Clinical Research and of Global Regulatory Oncology Research Policy at Bristol-Myers Squibb (BMS), has been elected to the national board of directors of The Leukemia & Lymphoma Society (LLS), effective July 1, 2016. His term will run through June 30, 2019 and is subject to renewal. Dr. Canetta has more than ...

Kathleen Meriwether Elected to LLS National Board of Directors

Rye Brook, N.Y. (June 28, 2016) – Kathleen Meriwether, Americas Life Sciences Leader for Ernst & Young LLP’s (EY) Fraud Investigation & Dispute Services practice, has been elected to the national board of directors of The Leukemia & Lymphoma Society (LLS), effective July 1, 2016. Her term will run through June 30, 2019 and is subject to renewal. Meriwether, specializes in assisting health sciences ...

Pages

Meet the LLS Experts

Louis J. DeGennaro, Ph.D.
President and CEO

More than 25 years of research and drug development, and recognized as the key architect of LLS's cures and access agenda.

Lee Greenberger, Ph.D.,
Chief Scientific Officer

Over 25 years of experience in discovery and development of Oncology drugs. Leads planning and strategy for LLS research programs.

Andrew S. Coccari, Jr.,
EVP, Chief Product Officer

With more than 20 years of leadership in product development, marketing and sales experience in both consumer and wholesale industry spaces, Coccari is responsible for conception, development and implementation of all LLS fundraising campaigns.

Beatrice Abetti, LCSW, Director of Information Resource Center

Clinical social worker and leader of LLS’s Information Resource Center, providing highly specialized blood cancer information, education and support for patients and their families.

Media Contact

Have media inquiries? Contact us between 9 a.m. and 5 p.m. ET, Monday through Friday: